Nuclear Medicine research
The Nuclear Medicine department’s objective is to provide a comprehensive and timely clinical nuclear medicine service.
A wide range of clinically relevant studies are available including cardiac, 18F-FDG-positron emission tomography (PET), bone and lung scans. We take a lead role in training of nuclear medicine specialists, radiology registrars and technologists, with our department one of the busiest accredited training sites for nuclear medicine and the busiest accredited training site for nuclear cardiology in Australia.
Our research areas include not only nuclear medicine and PET, but also other specialties via collaboration with various institutions and hospital departments such as Cardiology, Endocrinology, Transplantation Medicine, Psychiatry, Cancer Care and Surgical Units. Nuclear medicine techniques employed span conventional to advanced gamma camera and PET imaging technologies.
Current research
Radiation synovectomy
We conducted a retrospective review of 90 yttrium radiosynovectomy carried out on 167 joints between 2000 and 2010 to assess clinical response and complication rates in patients (n = 119) who had the procedure for either rheumatoid, psoriatic, hemophilic, large joint mono-arthropathy or other miscellaneous arthropathies refractory to conventional therapy.
Find out moreMonitoring lymphoma with PET
18F-FDG PET scanning is considered the standard of care for baseline staging and assessment of treatment response for higher grade lymphomas.
Find out morePublications
Normal brain metabolism on FDG PET/MRI during childhood and adolescence
Barber TW, Veysey D, Billah B, Francis P
(2018), Nucl Med Commun, 39(11), 1022-1032
A pilot study of cardiopulmonary exercise testing and cardiac stress positron emission tomography before major non-cardiac surgery
Ferguson MT, Hofman MS, Ismail H, Melville A, Yap KSK, Hicks RJ, Wright S, Riedel B
(2018), Anaesthesia, 73(12), 1524-1530
DOI: 10.1111/anae.14447
Does addition of a diagnostic contrast-enhanced CT to a contemporaneous PET/CT provide incremental value in patients for restaging of colorectal carcinoma?
Yap KSK, Mehta O, Lau WFE, Akhurst T, Warrier S, Heriot A, Hicks RJ
(2018), Eur J Hybrid Imaging, 2, 28